Literature DB >> 35129759

Stem Cell Therapies for Restorative Treatments of Central Nervous System Ischemia-Reperfusion Injury.

Ge Li1,2, Ping Zhu3,4,5,6,7,8, Qi-Song Su9,10, Dong-Lin Zhuang9,11, Moussa Ide Nasser9, Xiyalatu Sai12,13, Gang Deng9,14.   

Abstract

Ischemic damage to the central nervous system (CNS) is a catastrophic postoperative complication of aortic occlusion subsequent to cardiovascular surgery that can cause brain impairment and sometimes even paraplegia. Over recent years, numerous studies have investigated techniques for protecting and revascularizing the nervous system during intraoperative ischemia; however, owing to a lack of knowledge of the physiological distinctions between the brain and spinal cord, as well as the limited availability of testing techniques and treatments for ischemia-reperfusion injury, the cause of brain and spinal cord ischemia-reperfusion injury remains poorly understood, and no adequate response steps are currently available in the clinic. Given the limited ability of the CNS to repair itself, it is of great clinical value to make full use of the proliferative and differentiation potential of stem cells to repair nerves in degenerated and necrotic regions by stem cell transplantation or mobilization, thereby introducing a novel concept for the treatment of severe CNS ischemia-reperfusion injury. This review summarizes the most recent advances in stem cell therapy for ischemia-reperfusion injury in the brain and spinal cord, aiming to advance basic research and the clinical use of stem cell therapy as a promising treatment for this condition.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cerebral ischemia–reperfusion injury; Functionally enhanced stem cells; Prototype stem cells; Spinal cord ischemia–reperfusion injury; Stem cell therapy

Year:  2022        PMID: 35129759     DOI: 10.1007/s10571-022-01204-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  131 in total

Review 1.  Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.

Authors:  K Abe
Journal:  J Cereb Blood Flow Metab       Date:  2000-10       Impact factor: 6.200

2.  Origin of new glial cells in intact and injured adult spinal cord.

Authors:  Fanie Barnabé-Heider; Christian Göritz; Hanna Sabelström; Hirohide Takebayashi; Frank W Pfrieger; Konstantinos Meletis; Jonas Frisén
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

3.  CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

4.  Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes.

Authors:  Marco Bacigaluppi; Gianluca Luigi Russo; Luca Peruzzotti-Jametti; Silvia Rossi; Stefano Sandrone; Erica Butti; Roberta De Ceglia; Andrea Bergamaschi; Caterina Motta; Mattia Gallizioli; Valeria Studer; Emanuela Colombo; Cinthia Farina; Giancarlo Comi; Letterio Salvatore Politi; Luca Muzio; Claudia Villani; Roberto William Invernizzi; Dirk Matthias Hermann; Diego Centonze; Gianvito Martino
Journal:  J Neurosci       Date:  2016-10-12       Impact factor: 6.167

5.  Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke.

Authors:  Ishraq Alim; Joseph T Caulfield; Yingxin Chen; Vivek Swarup; Daniel H Geschwind; Elena Ivanova; Javier Seravalli; Youxi Ai; Lauren H Sansing; Emma J Ste Marie; Robert J Hondal; Sushmita Mukherjee; John W Cave; Botir T Sagdullaev; Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

6.  Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells.

Authors:  Tamir Ben-Hur; Ofra Ben-Menachem; Victoria Furer; Ofira Einstein; Rachel Mizrachi-Kol; Nikolaos Grigoriadis
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

7.  Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury.

Authors:  Marshall T Bell; Ferenc Puskas; Viktor A Agoston; Joseph C Cleveland; Kirsten A Freeman; Fabia Gamboni; Paco S Herson; Xianzhong Meng; Phillip D Smith; Michael J Weyant; David A Fullerton; T Brett Reece
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

Review 8.  Stem cell therapy for neurological disorders.

Authors:  M Alessandrini; O Preynat-Seauve; K De Bruin; M S Pepper
Journal:  S Afr Med J       Date:  2019-09-10

Review 9.  The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.

Authors:  Sebastian Altenhöfer; Pamela W M Kleikers; Kim A Radermacher; Peter Scheurer; J J Rob Hermans; Paul Schiffers; Heidi Ho; Kirstin Wingler; Harald H H W Schmidt
Journal:  Cell Mol Life Sci       Date:  2012-05-31       Impact factor: 9.261

10.  Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain.

Authors:  Robert H Andres; Nobutaka Horie; William Slikker; Hadar Keren-Gill; Ke Zhan; Guohua Sun; Nathan C Manley; Marta P Pereira; Lamiya A Sheikh; Erin L McMillan; Bruce T Schaar; Clive N Svendsen; Tonya M Bliss; Gary K Steinberg
Journal:  Brain       Date:  2011-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.